Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) ( DrugBank: Bevacizumab, Imatinib )

1 disease
IDDisease name (Link within this page)Number of trials
87Pulmonary veno-occlusive disease1

87. Pulmonary veno-occlusive disease

Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 45 
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries